NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 418, 235-239
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA130932-05)
- Susan G. Komen for the Cure (PDF12229484)
This publication has 77 references indexed in Scilit:
- Cracking the Estrogen Receptor's Posttranslational Code in Breast TumorsEndocrine Reviews, 2011
- FOXA1 is a key determinant of estrogen receptor function and endocrine responseNature Genetics, 2010
- FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific TranscriptionCell, 2008
- Estrogen receptors outside the nucleus in breast cancerBreast Cancer Research and Treatment, 2007
- Identification of proteins within the nuclear factor-κ B transcriptional complex including estrogen receptor-αAmerican Journal of Obstetrics and Gynecology, 2007
- Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2Nature Cell Biology, 2007
- Genome Regulation by Polycomb and Trithorax ProteinsCell, 2007
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1Cell, 2005
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000